HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

A feat once deemed impossible has been accomplished --- the deprogramming of a fully differentiated human cell into an embryonic stem cell. Two laboratories report a breakthrough that may one day ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

Over the last two and a half decades, advancements in stem cell biology and immunology have improved the potential for cell therapy as a treatment for diabetes. Stem cells from different sources can ...

A new stem cell treatment may offer hope for Parkinson's disease. Keck Medicine of USC is investigating a unique therapy that ...

Geron Corp., the company that started the first U.S.-approved trial of human embryonic stem cells, fell the most in more than 11 years after research costs and regulatory complexities caused it to end ...

Researchers have uncovered how proteins normally active only before birth can drive aggressive lung cancer, opening new avenues for future treatments. The study found that more aggressive lung cancers ...

Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...